Back to search

Article

Development of a novel peripherally acting alpha2A-adrenergic receptor antagonist for anti-diabetic

2024-12-23

Abstract excerpt

<h4>Summary</h4> Yohimbine, a potent alpha2A-adrenergic receptor (α 2A AR) antagonist, was found therapeutic potential for type 2 diabetes through improving insulin release. However, the adverse side effects mediated by its actions in the brain hampered its use. Here, based on molecular docking analysis and structural modification, we have developed a novel peripherally acting yohimbine derivative (CDS479-2). Cr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24dc8fb2-eb0b-5c92-9a07-508195bb42bc
DOI
10.1101/2024.12.17.628818
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of a novel peripherally acting alpha2A-adrenergic receptor antagonist for anti-diabeticDOI 10.1101/2024.12.17.628818
Select a neighboring publication to make it the new centre.